glp 1 weight loss scam New Study Finds Online Advertising for Compounded Diabetes and Weight-Loss Drugs May Mislead Consumers Pre-approved GLP-1 prescription scam could

Each persons unique circumstances will influence the duration of treatment needed to achieve best weight loss results

Peptual TB-500 + BPC-157 Nasal Spray Synergistic nasal peptides to support recovery and tissue pathways

doi: 10.1016/j.neurobiolaging.2021.07.014, 24 IslamN.HashemR.GadM.BrownA.LevisB.RenouxC.et al

On Monday, 24th November, Novo Nordisk published a press release, explaining that the Evoke and Evoke+ trials did not confirm superiority of semaglutide versus placebo in the reduction of progression of Alzheimers disease. Although the researchers did report significant reductions in biomarkers associated with Alzheimers, there was no reduction in disease progression in either trial

This is a fascinating area, but we should be cautious